ArticleScientific reports2025
Multimodal multi-instance evidence fusion neural networks for cancer survival prediction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Artificial intelligence-powered liquid biopsy in cancer: a paradigm shift in cancer detection and personalized care.Cancer cell international · 2026Review
- Survival prediction for bladder cancer using multimodal data with quantum neural networks and transformer architectures.Scientific reports · 2026Article
- A unified multi modal transformer framework for breast cancer recurrence prediction and survival analysis.Scientific reports · 2026Article
- Resilient Sinkhorn-Based Optimal Transport Late Fusion Framework for Breast Cancer Diagnosis.Cancer informatics · 2026Article
- Robust Multimodal Fusion for Survival Prediction in Cancer Patients.Cancer informatics · 2025Article
- MCAMamba: A multimodal method with bidirectional cross-attention and state space model for cancer survival prediction.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Accurate cancer survival prediction plays a crucial role in assisting clinicians in formulating treatment plans. Multimodal data, such as histopathological images, genomic data, and clinical information, provide complementary and comprehensive information, significantly enhancing the accuracy of this task. However, existing methods, despite achieving some promising results, still exhibit two significant limitations: they fail to effectively utilize global context and overlook the uncertainty of different modalities, which may lead to unreliable predictions. In this study, we propose a multimodal multi-instance evidence fusion neural network for cancer survival prediction, called M2EF-NNs. Specifically, to better capture global information from images, we employ a pre-trained vision transformer model to extract patch feature embeddings from histopathological images. Additionally, we are the first to apply the Dempster-Shafer evidence theory to the cancer survival prediction task and introduce subjective logic to estimate the uncertainty of different modalities. We then dynamically adjust the weights of the class probability distribution after multimodal fusion based on the estimated evidence from the fused multimodal data to achieve trusted survival prediction. Finally, the experimental results on three cancer datasets demonstrate that our method significantly improves cancer survival prediction regarding overall C-index and AUC, thereby validating the model's reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.